StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$54.99−3.20 (-5.50%)

Close on Nov 16, 2026Market cap $7.16BP/E –Yield –

10x Genomics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for 10x Genomics

10x Genomics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More 10x Genomics figures

See a number that looks wrong?